Skip to main content

    blog · category

    drug discovery.

    8 articles on drug discovery, newest first.

    the log

    notes on drug discovery.

    8 articles · Drug Discovery

    all articles

    latest article · Drug Discovery

    DiffDock vs GNINA vs AutoDock Vina: Choosing a Docking Method

    DiffDock finds where a ligand binds on a whole protein; GNINA and AutoDock Vina are strongest when you already know the pocket. Here is how the published benchmarks compare, why pose accuracy is not physical validity, and why no docking score is a binding affinity.

    · 8 min read

    more in Drug Discovery

    • Drug Discovery · 12 min read

      In Silico vs In Vivo ADMET: How Accurate Is AI ADMET Prediction?

      An in silico ADMET panel ranks compounds; in vitro assays measure them and in vivo studies measure the animal. Here is what each layer actually resolves, where predictions fail, and how to decide when a computational flag justifies an experiment.

    • Drug Discovery · 15 min read

      DeepPurpose DTI Prediction vs a Binding Assay: What the Score Means

      A DeepPurpose drug–target interaction score is a sequence-only estimate of the label its checkpoint was trained on: pKd on a kinase panel, pIC50 from BindingDB, or a KIBA score. A binding assay measures the interaction itself. What each number is, how far apart they can be, and how to use the score without mistaking it for a Kd.

    • Drug Discovery · 11 min read

      DiffDock vs Chai-1 vs Boltz-2: Co-Folding vs Docking

      Docking places a ligand into a receptor structure you already have. Co-folding predicts the whole complex from sequence. Here is what DiffDock, Chai-1 and Boltz-2 each need as input, what their confidence scores mean, what Boltz-2's affinity head is and is not, and when to reach for each.

    • Drug Discovery · 10 min read

      GenMol vs REINVENT 4: Discrete Diffusion vs RL Molecule Generation

      GenMol samples molecules as fragments with masked discrete diffusion; REINVENT 4 steers an RNN or transformer prior with reinforcement learning and curriculum scoring. Here is what each one is built for, what GuacaMol and MOSES do and do not measure, and how to run them.

    • Drug Discovery · 15 min read

      ADMET-AI vs SwissADME vs pkCSM: Choosing a Free ADMET Tool

      ADMET-AI, SwissADME and pkCSM are all free, and they are not the same kind of instrument. One returns learned probabilities and regression values at library scale, one returns rules and physicochemical readouts, one returns regression and classification from graph-based signatures. Here is how to pick.

    • Drug Discovery · 18 min read

      RDKit logP vs Measured logP and Solubility: How Far Do Calculated Properties Go?

      RDKit's MolLogP is the Wildman–Crippen atom-contribution model, and TPSA is a fragment sum that stands in for 3D polar surface area. Both are fast, deterministic and good enough to rank and filter compounds. Neither is a measurement. A practical comparison of calculated logP, TPSA and the rule-of-five descriptors against shake-flask logP and measured aqueous solubility, with the published error bars.

    • featured · Drug Discovery · 7 min read

      A Practical Guide to ADMET Prediction for Drug Candidates

      Learn how to predict absorption, distribution, metabolism, excretion, and toxicity properties of drug candidates using AI models — before spending resources on synthesis.

    newsletter

    get the next one by email.

    occasional updates on new features, research progress, and what we learned the hard way.
    Loading...